MLH3 and prostate carcinoma: The overview of adverse effects of MLH3 SNPs for individual malignancies is shown in Figure 4: rs175080 has an adverse effect on hepatocellular, lung and cervical cancers, whereas rs28756990 and rs175057 were associated with prostate cancer only.